The survey also showed that high drug costs and artificial intelligence are topmost among the respondent’s concerns.

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

In this new role, Flaster will lead Cigna Healthcare’s clinical organization, focusing on initiatives to improve customer ...

Panelists discuss the potential role of emerging treatments in the progressive pulmonary fibrosis (PPF) landscape if approved ...

As the nation is again under the reigns of a Trump administration and a Republican-led Congress, debates on reducing spending ...

Panelists discuss the key gaps and unmet needs in current management strategies for progressive pulmonary fibrosis (PPF) and ...

A panelist discusses how she proactively addresses safety concerns about neurokinin-targeted therapies through evidence-based ...